drugset / Trial / NCT04482985

Meclizine Plasma Levels in Responders and Non-responders

NCT04482985

Phase 4 Unknown 50 enrolled Medical Corps, Israel Defense Force
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Motion sickness is a debilitating condition that can effect many crew members. Meclizine has long been known as an effective anti motion sickness drug. The response to the drug is variable - some are responders, while others are resistant to the drug. The aim of the present study is to examine whether there is a correlation between meclizine plasma levels and clinical response.

Timeline

Start
2020-09-01
Primary completion
2021-09-01
Completion
2021-09-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Meclizine Small molecule

Indications